Droia Genetic Disease News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Droia genetic disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Droia Genetic Disease Today - Breaking & Trending Today

Two New Life Sciences VC Funds Established as Investment Appetite Grows

Two new venture capital funds, Droia Ventures and Perceptive Advisors closed on new funds to invest in early-stage life science companies. ....

New York , United States , Bruxelles Capitale , George Golumbeski , Janwillem Naesens , Luc Dochez , Chris Garabedian , Business Development At Celgene , European Union , Million Venture Fund , Perceptive Xontogeny Venture Fund , Droia Venture New Fund Worth , Perceptive Advisor Life Science Fund , Venture Capital , Venture New Fund Worth , Droia Genetic Disease , Business Development , Advisors Closes , Perceptive Advisors , Wo New Life Sciences Vc Funds Established As Investment Appetite Grows , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ப்ரூக்ஸெல்ஸ் தலைநகரம் , கிறிஸ் கரபெடியன் , ஐரோப்பிய தொழிற்சங்கம் , துணிகர மூலதனம் ,

European Commission grants Vico Therapeutics Orphan Drug Designation for VO659, an Investigational Therapy for Spinocerebellar Ataxia

European Commission grants Vico Therapeutics Orphan Drug Designation for VO659, an Investigational Therapy for Spinocerebellar Ataxia
News provided by
Share this article
a Leiden, the Netherlands, based biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, today announced that the European Commission (EC) has granted orphan drug designation for VO659, Vico s investigational antisense oligonucleotide therapy for the treatment of Spinocerebellar Ataxia (SCA). The orphan designation was based on a positive opinion from the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP). Vico previously received orphan drug designation for VO659 in Huntington Disease.
Spinocerebellar Ataxias ....

Noord Holland , Spinocerebellar Ataxias , Judith Van Deutekom , Rupert Sandbrink , Gail Mandel , Pureos Bioventures , Luc Dochez , Gertjan Bartlema , Josh Mandel Brehm , Committee For Orphan Medicinal Products , European Union , European Medicines Agency , European Commission , Lifespring Life Sciences Communication , Spinocerebellar Ataxia , Orphan Medicinal Products , Chief Medical Officer , Chief Business Officer , Spring Life Sciences Communication , Huntington Disease , Life Science Partners , Kurma Partners , Droia Genetic Disease , Polaris Partners , Vico Therapeutics , நூற்த் ஹாலண்ட் ,